Ovarian cancer vaccine (AVAX Technologies)

N/A

Report date: 2022/11/25 17:25:22

Base Information

Drug NameOvarian cancer vaccine (AVAX Technologies)
Drug Alias Name卵巢癌疫苗 - AVAX TechnologiesDNP-Modified Ovarian Cancer VaccineOVaxO-Vax
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAvax Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvax Technologies Inc
Active IndicationsN/A
Inactive IndicationsAdenocarcinoma

Other Information

ATC CodeN/A
Related LinksN/A